Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flow limitation while breathing HeO2

L C Lands1, T D Charge, A L Coates

  • 1Respiratory Medicine Service, McGill University-Montreal Children's Hospital Research Institute, Quebec.

Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric lung function testing during a pandemic: An international perspective.

Paediatric respiratory reviews·2020
Same author

Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2017
Same author

The benefits of newborn screening for cystic fibrosis: The Canadian experience.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2016
Same author

Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1.

British journal of pharmacology·2015
Same author

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2014
Same author

Asthma and chronic sickle cell lung disease: a dynamic relationship.

Paediatric respiratory reviews·2010

Investigating the volume of isoflow (VisoV) for small airways function, this study found dynamic airway compression occurs even with helium-oxygen (HeO2) breathing. This challenges the use of VisoV due to high variability in flow limitation measurements.

Area of Science:

  • Pulmonary Physiology
  • Respiratory Mechanics
  • Small Airways Function

Background:

  • Flow limitation during maximum expiratory flow-volume curves (MEFVC) typically occurs below 70% vital capacity (VC).
  • The volume of isoflow (VisoV) compares MEFVC in air to HeO2 to assess small airways, but exhibits high intra-subject variability.
  • Variability in VisoV may stem from an inability to achieve flow limitation when breathing HeO2.

Purpose of the Study:

  • To investigate if high intra-subject variability in VisoV is due to an inability to achieve flow limitation while breathing HeO2.
  • To determine if expiratory muscle contraction velocity is insufficient to overcome increased expiratory flows and cause dynamic airway compression with HeO2.

Main Methods:

  • Seven healthy adult males performed maximal vital capacity (VC) expirations with esophageal balloons in a body plethysmograph.

Related Experiment Videos

  • Subjects breathed both air and an 80% helium, 20% O2 (HeO2) mixture.
  • Transpulmonary pressure-flow plots were analyzed at 70%, 50%, and 25% VC to assess flow limitation.
  • Main Results:

    • Flow limitation in air was observed in 3, 6, and 7 subjects at 70%, 50%, and 25% VC, respectively.
    • In HeO2, flow limitation was achieved in only 1 and 4 subjects at 70% and 50% VC, respectively.
    • At 25% VC, 6 out of 7 subjects demonstrated flow limitation despite HeO2 breathing, with one subject showing glottic closure.

    Conclusions:

    • Dynamic airway compression occurs even with the increased expiratory flows associated with breathing HeO2.
    • The findings suggest that the inability to consistently achieve flow limitation in HeO2 contributes to the high variability observed in VisoV measurements.
    • This challenges the reliability of VisoV as a sole indicator of small airways function when using HeO2 mixtures.